Pharmacology of chronic pain.
Chronic pain, which is associated with prolonged tissue damage or injuries to the peripheral or central nervous system, results from a number of complex changes in nociceptive pathways. These include alterations of cell phenotype and changes in the expression of proteins such as receptors, transmitters and ion channels, as well as modifications of neural structure, for example, cell loss, nerve regeneration and synaptic reorganizations. The resultant increase in neural excitability can be reduced with receptor-selective drugs that block peripheral or central chemical mediators or that control ectopic activity or cellular phenotype changes. In this article, Andy Dray, Laszlo Urban and Anthony Dickenson focus on some current mechanistic aspects of chronic pain imposed by inflammation and peripheral neuropathy, and review in particular the molecular changes involving the pharmacology of nociceptive pathways since these have important implications for the management of pain.
Dray
A
A
Sandoz Institute for Medical Research, London, UK.
Urban
L
L
Dickenson
A
A
D000700:Analgesics / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D010525:Peripheral Nerves / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects
D000700:Analgesics